Credit Suisse Ag Elanco Animal Health Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Credit Suisse Ag holds 563,945 shares of ELAN stock, worth $7.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

563,945

Previous 579,575 2.7%

Holding current value

$7.92 Million

Previous $8.64 Million 6.32%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$14.37 - $16.46 $224,603 - $257,269	-15,630 Reduced 2.7%	563,945 $9.18 Million
Q4 2023 Feb 08, 2024	BUY	$8.6 - $14.94 $7,430 - $12,908	864 Added 0.15%	579,575 $8.64 Million
Q3 2023 Nov 13, 2023	SELL	$9.81 - $12.62 $247,182 - $317,986	-25,197 Reduced 4.17%	578,711 $6.5 Million
Q2 2023 Aug 11, 2023	SELL	$8.08 - $10.37 $4.71 Million - $6.04 Million	-582,631 Reduced 49.1%	603,908 $6.08 Million
Q1 2023 May 10, 2023	SELL	$8.79 - $14.58 $4.62 Million - $7.67 Million	-525,885 Reduced 30.71%	1,186,539 $11.2 Million
Q4 2022 Feb 13, 2023	SELL	$11.49 - $13.65 $189,125 - $224,679	-16,460 Reduced 0.95%	1,712,424 $20.9 Million
Q3 2022 Nov 10, 2022	BUY	$12.41 - $32.42 $870,797 - $2.27 Million	70,169 Added 4.23%	1,728,884 $21.5 Million
Q2 2022 Aug 12, 2022	BUY	$19.63 - $26.62 $246,356 - $334,081	12,550 Added 0.76%	1,658,715 $32.6 Million
Q1 2022 May 16, 2022	BUY	$24.65 - $29.0 $516,565 - $607,724	20,956 Added 1.29%	1,646,165 $42.9 Million
Q4 2021 Feb 14, 2022	BUY	$27.74 - $34.09 $4.11 Million - $5.05 Million	148,212 Added 10.03%	1,625,209 $46.1 Million
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $6.11 Million - $7.68 Million	209,179 Added 16.5%	1,476,997 $47.1 Million
Q2 2021 Aug 16, 2021	SELL	$28.76 - $35.98 $4.11 Million - $5.14 Million	-142,824 Reduced 10.12%	1,267,818 $44.8 Million
Q1 2021 May 14, 2021	BUY	$27.85 - $34.49 $11.8 Million - $14.6 Million	422,166 Added 42.71%	1,410,642 $41.5 Million
Q4 2020 Feb 12, 2021	SELL	$27.53 - $33.79 $7.38 Million - $9.06 Million	-268,168 Reduced 21.34%	988,476 $30.3 Million
Q3 2020 Nov 13, 2020	BUY	$21.1 - $29.13 $11.9 Million - $16.5 Million	565,677 Added 81.87%	1,256,644 $35.1 Million
Q2 2020 Aug 12, 2020	BUY	$18.94 - $24.93 $4.53 Million - $5.97 Million	239,327 Added 52.99%	690,967 $14.8 Million
Q1 2020 May 13, 2020	SELL	$16.68 - $32.25 $9.78 Million - $18.9 Million	-586,445 Reduced 56.49%	451,640 $10.1 Million
Q4 2019 Feb 12, 2020	BUY	$25.29 - $29.45 $1.2 Million - $1.4 Million	47,449 Added 4.79%	1,038,085 $30.6 Million
Q3 2019 Nov 12, 2019	BUY	$25.62 - $34.96 $3.3 Million - $4.5 Million	128,742 Added 14.94%	990,636 $26.3 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $5.68 Million - $6.35 Million	-182,481 Reduced 17.47%	861,894 $29.1 Million
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $30.3 Million - $34.3 Million	1,044,375 New	1,044,375 $33.5 Million

Others Institutions Holding ELAN

# of Institutions

438

Shares Held

473M

Call Options Held

4.07M

Put Options Held

689K

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.66B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account